TAB2 and hepatocellular carcinoma: Li et al. found that ESR1 and TAB2 expression levels were decreased in hepatocellular carcinomas compared to those in adjacent normal tissues and that the ESR1 expression was significantly associated with the expression of TAB2 [27].